Wanda Dyson, MD testified at the National Academy of Sciences in support of Physiologic Restoration which she prescribes for her patients. She credits PR for saving her life

Thanks to your activism, the FDA has agreed to study bioidentical hormone replacement therapy. But the threat to hormones still looms. For months now, we’ve been telling you about the FDA’s attack on estriol, progesterone, and other bioidentical hormones that are made for individual patients at specialized pharmacies. Now, thanks to the activism of ANH members and other stakeholders, the agency has recently announced that they have asked the National Academies of Science, Engineering, and Medicine (NASEM) to conduct a study on bioidentical hormone replacement therapy (BHRT) more

Bioidentical Hormones are under attack again from Medscape, an online medical information site funded by the major drug companies. In spite of all the “Guidelines” created by medical organizations advising women to use their “FDA approved” synthetic hormone products, women and their physicians have rejected these “Guidelines” and have switched to bioidentical more

The National Academies of Sciences, Engineering, and Medicine (NASEM) are conducting a research study to examine the clinical utility of compounded bio-identical hormone replacement therapy (BHRT). To help support the study's conclusions and recommendations, the study's expert committee is seeking input regarding the use, safety and effectiveness of compounded BHRT more

The Women’s Hormone Network announced its upcoming educational hormone symposium for medical practitioners. Entitled, 21st Century Hormone Advancements: The Practitioner’s Comprehensive Guide to Bioidentical Hormones through Menopause and Andropause, the symposium will be held November 7-10, 2019 at the Marriott Irvine more

An update on efforts to preserve access to bioidentical hormone replacement therapy. Action Alert! We’ve been telling you about the FDA’s efforts to curtail or eliminate patient access to bioidentical hormones, as well as potential intellectual property challenges from the pharmaceutical industry that would prevent compounding pharmacies from preparing these important more

WHN is a registered 501(c)3 not-for-profit corporation to promote, advocate, and advance women’s wellbeing and longevity through clinical research and education about the benefits of Physiologic Restoration to reduce the symptoms of hormone imbalance and degenerative decline.